China Regenerative Medicine International Limited (08158.HK)

China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. The company employs 24 full-time employees The company went IPO on 2001-07-18. The firm is engaged in the supply and sale of medical products and medical equipment. In addition, the Company is engaged in the provision of various health management services such as health assessment, detoxification treatment, homeostasis, organ maintenance and immune system enhancement.